Company ProfilePremium

BN Agrochem Limited (formerly Arihant Tournesol Limited)

Company Profile Analysis

Tickers: BNAGROCHEM.NS, 526125.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
BN Agrochem Limited - Company showcase

Year Founded & Workforce

1991

BN Agrochem Limited logo

BN Agrochem Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

BN Agrochem Limited Overview

BN Agrochem Limited is a re-activated listed shell turned edible-oil and agri-commodity trading platform. For most of its life as Arihant Tournesol it was a small Solapur-based sunflower and soybean solvent-extraction and refining company marketing oil under the "Sunari" brand; operations ceased and the stock became dormant, at one point suspended for listing non-compliance. In December 2022 the company was acquired by Anubhav Agarwal of the Noida-based BN Group, renamed BN Holdings and then BN Agrochem, recapitalised through a USD 40 million FCCB programme listed in Mauritius, and given overseas trading subsidiaries in Singapore and London. Revenue rose from nil in FY2023 to ₹873 Cr in FY2026, largely from offshore edible-oil and agri-product trading at thin margins. The investment case now hinges on a pending three-way amalgamation with BN Group's operating companies (A1 Agri Global, B.N. Agritech, Salasar Balaji Overseas), which would convert it into the group's consolidated listed edible-oil vehicle.


Company's own description (Annual Reports FY2022-23 and FY2023-24): The company describes itself as engaged in acquiring interests in companies that deal in manufacturing and trading various kinds of oil, oil seeds, solvent extraction, extracted oil cakes and refined oil. The FY2022-23 report states it was recently acquired by Mr. Anubhav Agarwal, promoter and director and key personnel of the BN Group. The FY2023-24 report, as summarised by Screener, adds an aspiration to go international as a Food and FMCG company and to expand into renewable energy. The FY2024-25 report states the company continues to focus on the edible oils and agri-products trading segment. Data vendors (Kotak Neo) further note that the objects have been broadened to include solar and wind energy systems, software development, system integration and IT-enabled services.

Independent characterisation: In substance, BN Agrochem today is a commodity trading business, not a manufacturer. The evidence:

  • Fixed assets were approximately ₹1 Cr at 31 March 2026 against revenue of ₹873 Cr (consolidated), an asset intensity inconsistent with crushing or refining capacity.

  • Operating (EBITDA) margins were 2.5% in FY2025 and 2.6% in FY2026 (Screener, consolidated) — typical of merchant trading of edible oils, not of branded FMCG.

  • Screener's AI-extracted insights flag a top-customer concentration metric naming KLB International, indicating material dependence on a small number of counterparties (percentage not publicly visible).

Business model / revenue model mix:

Value-chain position: Mid-stream merchant/trader between origin suppliers (palm, soybean, sunflower oil and oilseeds) and industrial buyers, refiners and distributors. Post-amalgamation, the company would absorb B.N. Agritech and related entities, which—based on group disclosures—are involved in edible-oil processing and distribution in India, moving it upstream into processing and downstream into branded distribution (the precise asset base of the transferor companies is not publicly disclosed in sources reviewed).

Customer types: Business-to-business buyers of edible oil and agri-commodities (named counterparty: KLB International, per Screener insight tag). Retail consumers were served only historically under the "Sunari" brand.

End-markets: Indian and international edible oil markets (palm, soybean, sunflower, mustard), oilseed meal (de-oiled cake) for animal feed, and—per BN Group's stated plans—African edible oil and soap markets.

Strategy

Stated strategic themes (Annual Reports FY2022-23 to FY2024-25, company website, Screener key points):

  1. Build an internationally recognised edible-oils and FMCG company — the stated rationale for the 2022 acquisition by the BN Group promoter.

  2. International expansion via overseas subsidiaries — Singapore (palm oil wholesale hub) and London.

  3. Consolidate BN Group's operating businesses into the listed entity — the Scheme of Amalgamation, justified by operational synergies, centralised procurement and improved cash-flow management (NCLT coverage, ScanX).

  4. Diversify into a conglomerate — renewable energy (solar, wind) and technology services (software, system integration, ITeS) added to objects.

  5. Access international capital — USD 10 million foreign investment consideration (Apr 2023), followed by the USD 40 million FCCB programme on AFRINEX.

Initiative register (last 24 months):

ESG commitments / cost programmes: None publicly disclosed.

Medium-term financial targets / guidance: None publicly disclosed. The company does not issue guidance.

Products & Services

The company does not publish a product catalogue, price list or SKU data. The table records every product category referenced in public filings.

Flagship offerings: None currently named. No product launches, specifications or version years are publicly disclosed for the post-2022 business.

Product Portfolio

Product / brandSegmentDescriptionTarget customerPeriodPricing model

"Sunari" edible oil (legacy brand)

Edible oils

Branded edible cooking oil (sunflower/soy) produced at Solapur refinery

Retail and wholesale consumers in Maharashtra

1990s – mid-2000s; currently not disclosed as active

—

Crude & refined edible oils (palm, soybean, sunflower, etc.)

Trading

Bulk merchant trading of edible oils

Refiners, packers, industrial buyers, international counterparties (e.g., KLB International)

FY2024 – present

Commodity-linked, spot/contract (terms not disclosed)

Oil seeds

Trading

Trading of oilseeds

Crushers, processors

FY2024 – present

Commodity-linked

Extracted oil cakes / de-oiled cake (DOC)

Trading / legacy manufacturing

Protein meal from solvent extraction; feed input

Feed manufacturers, exporters (historic soybean meal order from Germany)

Historic; mentioned in current object description

Commodity-linked

Solvent extraction services

Legacy

Extraction of oil from seeds/cakes

—

1995 – mid-2000s

—

Other agricultural produce

Trading

General agri-produce trading

B2B

FY2024 – present

—

Soaps and palm by-products (planned, BN Group)

Africa expansion

Palm-oil-based by-products announced by BN Group

African retail via direct-to-store, later distributors

Announced Dec 2024; operations expected Q4 FY2027

—

Renewable energy (solar, wind systems)

New objects

Object-clause expansion

—

Not operational per filings

—

Software, system integration, ITeS

New objects

Object-clause expansion

—

Not operational per filings

—

“—” = not publicly disclosed.

Financial Narrative

Data basis: FY2022 figures are standalone (no subsidiaries existed). FY2023–FY2026 are consolidated (Screener / company results). Blank cells = not publicly disclosed or not available in sources reviewed.

Income Statement

Sources: Screener consolidated and standalone P&L; FY2025/FY2026 net profit ₹1,975.56 lakh and ₹3,436.72 lakh per company results (5paisa summary). Gross profit not disclosed (cost of goods sold not separately available in sources reviewed). Diluted EPS not separately disclosed; given FCCB conversions in FY2025, basic and diluted may differ materially for FY2025 (weighted share count rose from ~0.99 Cr to 9.78 Cr shares).

Note on EPS discontinuity: FY2024 EPS of -₹3.16 is on ~0.99 crore shares; FY2025 onwards EPS is on ~9.78 crore shares post-FCCB conversion. Per-share comparisons across FY2024/FY2025 are not like-for-like.

Margins & Growth

Analyst calculations. Revenue CAGR FY2024–FY2026 (2 years) ≈ 1,010% (from ₹7.09 Cr to ₹873.28 Cr); a 5-year CAGR is not meaningful because the FY2022 and FY2023 bases are zero.

Quarterly Trajectory (Consolidated)

Source: Screener consolidated quarterly results. Minor vendor differences: Q4FY26 revenue reported as ₹261.36 Cr (Screener), ₹261.72 Cr (Kotak Neo) and ₹261.36 Cr (company: ₹26,135.66 lakh); Q1FY27 revenue ₹257.51 Cr (Screener/Business Standard) vs ₹257.61 Cr (ScanX, company: ₹25,760.75 lakh).

Commentary — income statement: The business has three distinct phases. (i) FY2022–FY2024: a dormant shell with sub-crore expenses and no revenue, ending with a first ₹7.09 Cr trading quarter in Q4FY24 under the new promoter. (ii) FY2025: the ramp-up year, in which trading started in earnest only from Q3FY25 (after the Singapore and London subsidiaries were capitalised by FCCB proceeds). Reported profitability that year was flattered by other income: Q4FY25 recorded an operating loss of ₹40.55 Cr offset by ₹61.44 Cr of other income — the nature of which (FX gains on FCCB liabilities, fair-value gains, or reclassified trading income) is not disclosed in sources reviewed and is a key diligence item. (iii) FY2026: revenue nearly tripled to ₹873 Cr, but quarterly operating margins oscillated violently (11.7% in Q1, 0.6% in Q2, -8.4% in Q3, 1.6% in Q4), consistent with mark-to-market exposure on commodity positions or lumpy deal-level margins. Critically, FY2026 net profit (₹34.4 Cr) exceeded PBT (₹20 Cr) because of a large tax credit (tax rate -74%), concentrated in Q2FY26 when net profit of ₹17.92 Cr was booked on PBT of just ₹0.57 Cr. Stripping that out, FY2026 "core" earnings were materially lower than headline. Q1FY27 continued the low-margin pattern: revenue +27% YoY to ₹257.6 Cr, net profit -85% YoY to ₹2.98 Cr as EBITDA margin contracted from 11.71% to 2.29% (ScanX).

Standalone vs Consolidated

Source: company results as summarised by 5paisa (standalone FY2025 revenue ₹2,562.89 lakh; standalone FY2025 net loss ₹5,963.13 lakh; FY2026 standalone revenue ₹23,262.30 lakh and net profit ₹1,934.95 lakh). The FY2025 standalone loss of ~₹59.6 Cr alongside a consolidated profit implies large standalone charges (possibly FCCB discount amortisation/FX losses or impairments) offset by subsidiary profits.

Balance Sheet (Consolidated)

Source: Screener consolidated balance sheet; FY2022 paid-up capital ₹9.90 Cr per MCA registry (₹9,89,83,000). Short-/long-term split of borrowings, cash balance, goodwill and working-capital line items not publicly disclosed in sources reviewed. Book value per share ₹47.7 (Screener) reconciles to ₹467 Cr / 9.78 Cr shares.

Observations: The ₹72 Cr investment line that appeared in FY2024 and stayed flat through FY2026 is notable; in a consolidated balance sheet, investments in wholly owned subsidiaries would be eliminated, so this likely represents a non-consolidated investment (nature not publicly disclosed). The ₹294 Cr jump in reserves in FY2025 reflects securities premium from FCCB conversion (₹88 Cr face value of new shares plus premium), not retained earnings. Borrowings of ₹83 Cr at FY2025 (likely including unconverted FCCB liability) fell to ₹51 Cr in FY2026.

Cash Flow (Consolidated)

Source: Screener consolidated cash flow. FY2022 cash flow not available on consolidated basis.

Commentary — cash flow: FY2025 financing inflow of ₹327 Cr (FCCB proceeds) was deployed as ₹282 Cr of investing outflow — the composition of which (loans/advances, inter-corporate deposits, investments) is not disclosed in sources reviewed. Given that fixed assets and the investment line barely moved, a large part of this "investing" outflow likely represents loans or advances, potentially to related parties; this should be verified against the FY2025 annual report cash-flow notes. FY2026 is the first year of positive operating cash flow (₹24 Cr; CFO/EBITDA 123%), with ₹26 Cr of investing inflow (recoveries) used to reduce financing by ₹43 Cr.

Ratios

Sources: ROCE, debtor days, CCC and working-capital days from Screener; ROE/ROA/D/E/coverage/asset turnover are analyst calculations on average balances (FY2024 ROE from Screener's -8.88%). Current ratio, ROIC and net debt/EBITDA cannot be computed because cash and current-asset/current-liability splits are not publicly disclosed in sources reviewed. Screener flags "low interest coverage" on a trailing-twelve-month basis (TTM EBITDA -₹5 Cr).

Commentary — ratios: The 352 debtor days at FY2025 indicate that most of FY2025's ₹299 Cr revenue (booked largely in Q3–Q4) was still receivable at year-end; their collapse to 59 days by FY2026 is a positive. However, working-capital days rising from 79 to 172 shows that capital is tied up elsewhere (advances, other current assets). Zero inventory days across years corroborates the back-to-back trading model. ROE of ~8% on a heavily premium-inflated equity base is low for a trading business and well below the 13.4% three-year average Screener computes (which is skewed by FY2025's ROCE spike).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRelationshipJurisdictionFunction

BN Agrochem Limited

Listed parent

India (Mumbai)

Edible oil / agri trading; holding company

BN Holdings Singapore Pte. Limited

Subsidiary (incorporated as WOS 14 Feb 2024; listed as "Subsidiary" in FY2024-25 RPT note)

Singapore — OCBC Centre, 65 Chulia Street #42-07

Registered activities: wholesale trade of variety of goods; wholesale of palm oil; manufacture of edible oils and fats

BN Holdings Europe Limited

Wholly owned subsidiary (shares acquired 1 Jul 2024)

London, England

Overseas trading/expansion (detailed activities not publicly disclosed)

B.N. Corporate Park Pvt Limited

Related company (lessor)

India

Lease rent paid by the company

B.N. Agritech Limited

Promoter group company; proposed transferor; beneficiary of corporate guarantees

India

Edible-oil business with listed NCDs (MITCON Credentia as debenture trustee)

A1 Agri Global Limited

Promoter group; proposed transferor

India

Agri trading (details not publicly disclosed)

Salasar Balaji Overseas Private Limited

Promoter group; proposed transferor

India

Agri/overseas trading (details not publicly disclosed)

Revenue by Segment and Segment Margins & Growth (%)

MetricFY2024FY2025FY2026

Edible oils & agri trading revenue (INR Cr)

7.09299.41873.28

Segment operating profit / EBITDA (INR Cr)

-3.09722

Segment EBITDA margin (%)

-43.62.52.6

YoY revenue growth (%)

—4,123192

Contribution to total revenue (%)

100100100

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

007.09299.41873.28

Total expenses excl. interest & depreciation (INR Cr)

0.170.2010.18292851

EBITDA / Operating profit before other income (INR Cr)

-0.17-0.20-3.09722

Other income (INR Cr)

—-0.150230

Interest expense (INR Cr)

—0.020.0492

Depreciation (INR Cr)

—0001

Profit before tax (INR Cr)

—0-32220

Tax rate (%)

—009-74

Net profit (INR Cr)

—-0.37-319.7634.37

EPS basic (INR)

—-0.37-3.162.023.52

Dividend per share (INR)

00000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2024FY2025FY2026

EBITDA margin (%)

-43.62.52.6

PBT margin (%)

-42.37.32.3

Net margin (%)

-42.36.63.9

Revenue YoY growth (%)

—4,123192

Income Statement and Margin Analysis (%) (Quarterly)

MetricQ1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Revenue (INR Cr)

0007.090085.22214.19203.31216.49192.12261.36257.51

Operating profit (INR Cr)

-0.30-0.61-1.26-0.90-1.07-3.517.82-40.5523.811.28-16.154.225.91

OPM (%)

———-12.69——9.18-18.9311.710.59-8.411.612.30

Other income (INR Cr)

-0.040000.1006.2761.440.0108.760.370.03

Interest (INR Cr)

0000.011.252.882.931.640.450.520.480.500.52

Profit before tax (INR Cr)

-0.34-0.61-1.26-0.91-2.23-6.4111.1419.1723.180.57-8.063.895.21

Net profit (INR Cr)

-0.34-0.61-1.26-0.91-1.92-5.6910.0919.2520.0817.92-6.782.952.98

Income Statement

MetricFY2025FY2026

Standalone revenue (INR Cr)

25.63232.62

Consolidated revenue (INR Cr)

299.41873.28

Standalone net profit (INR Cr)

-59.6319.35

Consolidated net profit (INR Cr)

19.7634.37

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Equity share capital (INR Cr)

9.9010109898

Reserves (INR Cr)

—-1061294369

Total equity / net worth (INR Cr)

—071392467

Borrowings — total (INR Cr)

—118351

Other liabilities (INR Cr)

—001888

Total assets (INR Cr)

—072662526

Fixed assets (INR Cr)

—0011

Investments (INR Cr)

—0727272

Other assets incl. receivables & cash (INR Cr)

—00589453

Cash Flow

MetricFY2023FY2024FY2025FY2026

Cash from operating activities (INR Cr)

0-3-3824

Cash from investing activities (INR Cr)

0-72-28226

Cash from financing activities (INR Cr)

075327-43

Net cash flow (INR Cr)

0067

Capex (INR Cr)

0010

Free cash flow (INR Cr)

0-3-3924

Dividends paid (INR Cr)

0000

Buybacks (INR Cr)

0000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2024FY2025FY2026

ROE (%)

-8.98.58.0

ROA (%)

-8.35.45.8

ROCE (%)

-9274

Debt / equity (x)

0.010.210.11

Interest coverage, EBIT/interest (x)

—3.411.0

Asset turnover (x)

0.200.821.47

Debtor days

035259

Inventory days

000

Cash conversion cycle (days)

035259

Working capital days

-379172

Revenue by Region and Revenue by Region (%)

Region (derived)FY2024FY2025FY2026

India — standalone entity revenue (INR Cr)

7.0925.63232.62

Overseas subsidiaries — consolidated less standalone (INR Cr)

0273.78640.66

Total consolidated revenue (INR Cr)

7.09299.41873.28

Overseas share of total (%)

091.473.4

India share of total (%)

1008.626.6

Valuation Snapshot

MetricValueSource

Price (19 Oct 2026 close)

₹159

Screener

52-week high / low

₹420 / ₹158

Screener

1-year return

-60%

Screener

3-year CAGR

39%

Screener

5-year CAGR

96%

Screener

Shareholders (Sep 2026)

9,422

Screener

Share Price and Market Valuation

MetricPre-FCCB 2024Sep-2025Nov-2025Oct-2026

Share price (INR)

158368366159

Market cap (INR Cr)

1563,5973,5791,535

Valuation Multiples

MultipleBN AgrochemBasis

P/E (TTM)

89.9×

Screener (TTM EPS ₹1.74)

P/E (FY2026)

45.2×

Analyst: ₹159 / ₹3.52

P/B

3.33×

Screener (BV ₹47.7)

EV/Sales (TTM)

~1.7×

Analyst: (₹1,535 + ₹51 debt) / ₹927 Cr TTM revenue; gross of undisclosed cash

EV/EBITDA (FY2026)

~72×

Analyst: ~₹1,586 Cr / ₹22 Cr

Dividend yield

0.00%

Screener

Peer P/E (GAEL / RBS)

18.8× / 18.6×

Fyers

Capital Markets

ItemStatus

Dividend history

No dividends in any year reviewed (FY2013–FY2026); board cited conservation of resources (FY2021 AR)

Credit ratings (Moody's / S&P / Fitch)

Not rated by international agencies; domestic ratings not publicly disclosed in sources reviewed

Analyst consensus

No sell-side coverage identified

Debt maturity

FCCBs originally due May 2029 (largely converted); remaining borrowings ₹51 Cr at FY2026, maturity profile not disclosed

Analyst Conclusions

Management guidance: None issued. Consensus expectations: None (no coverage).

Bull case

  1. Amalgamation transforms the asset base. Absorbing B.N. Agritech (₹92.68 Cr issued capital, listed NCDs), A1 Agri Global and Salasar Balaji would turn an asset-light trader into an integrated edible-oil group, potentially lifting margins above the current 2–3%.

  2. Demonstrated ability to scale and convert to cash. Revenue went from ₹7 Cr to ₹873 Cr in two years, and FY2026 delivered positive operating cash flow (₹24 Cr) with receivable days down to 59.

  3. Optionality from Africa and Singapore. If the listed company becomes the vehicle for BN Group's USD 1 bn Africa programme, the growth runway is large relative to a ₹1,535 Cr market cap.

Bear case

  1. Earnings quality is weak. FY2026 net profit relied on a large tax credit; FY2025 relied on other income; TTM EBITDA is negative, leaving the stock on ~90× trailing earnings versus peers near 19×.

  2. Governance and related-party risk. 89.88% of equity is held by unnamed foreign companies from FCCB conversions, the promoter holds 5.93% directly but controls the transferor companies, and the listed entity is extending guarantees (₹25 Cr cumulative) to a promoter-group company.

  3. Dilution and value transfer. On analyst assumptions, the scheme could issue ~18.4 Cr new shares (~65% of the enlarged equity) to holders of promoter-group companies whose standalone financials are not publicly disclosed in sources reviewed; minority shareholders bear valuation risk.

Key catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhat to watch
EGM on ₹10 Cr guarantee22 Oct 2026Vote outcome; minority dissent
NCLT-convened shareholder & creditor meetingsWithin extended window (~Nov 2026)Approval margins, especially of public (non-promoter) shareholders
Final NCLT sanction of schemeFY2027 H2 (estimated)Effective date; final share count
Q2FY27 results~Nov 2026Margin recovery; tax rate normalisation; other income
FY2026 annual report notesAvailable on BSEComposition of ₹282 Cr FY2025 investing outflow; ₹72 Cr investment; related-party balances
Identity of foreign shareholdersOngoingAny lock-in, sell-down or acting-in-concert disclosures
BN Group Africa operationsTargeted Q4 FY2027Whether listed entity participates
Exchange surveillanceOngoingASM/GSM framework inclusion, further clarifications

Analyst verdict

BN Agrochem is best understood not as an edible-oil company in the conventional sense but as a listed vehicle in the middle of a promoter-led corporate reconstruction. The original Arihant Tournesol — a 1990s Solapur sunflower and soybean processor — no longer exists in any operational sense; what remains is a listing, a ₹10 face-value share structure and a new owner's ambition. Since December 2022 the BN Group has used that listing effectively: it raised USD 40 million through Mauritius-listed FCCBs, converted them into equity, set up trading arms in Singapore and London, and scaled revenue to ₹873 Cr in FY2026.

The quality of what has been built, however, remains unproven. Margins are commodity-trader thin and highly erratic; reported profits in each of the last two years leaned on non-operating items (other income in FY2025, tax credits in FY2026); trailing EBITDA is negative; and the largest use of FCCB money appears in investing cash flows whose nature is not transparently disclosed. Ownership is unusual — nearly nine-tenths of the equity sits with unnamed foreign companies — and the listed entity is already guaranteeing borrowings of a promoter-group company it intends to absorb.

The pending amalgamation is therefore the decisive event. If the transferor companies bring genuine processing and distribution assets with sound earnings, the merged entity could justify a premium to today's trading business. If not, minority shareholders face heavy dilution into opaque private businesses at a valuation that already prices in considerable success (≈90× trailing earnings, 3.3× book, versus integrated peers near 19× earnings).

On balance, the evidence supports a cautious, diligence-first stance. The stock's 60% decline over the past year reflects a market already discounting these risks, but until the transferor companies' financials, the identity of the foreign shareholders and the FY2025 cash deployment are clarified, BN Agrochem remains a high-risk special situation rather than an investable edible-oil franchise.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleSincePrior roles / profileEducationAge

Anubhav Agarwal

Promoter; Non-Executive Director (described as Non-Executive Chairman by Investing.com)

Board 30 Dec 2022; MD & CEO until 21 May 2025

Founder & MD of BN Group (edible oils, Noida); redesignated to non-executive to pursue business outside India

MBA (per FY2024-25 AR profile)

37–38 (vendor data)

Chintan Ajaykumar Shah

Whole-Time Director & CEO

21 May 2025

———

Manisha Kumari

Chief Financial Officer

2 Feb 2023

———

Rakesh Kumar Verma

Independent Non-Executive Director

27 Feb 2023

———

Shalu Saraf

Independent Non-Executive Director

27 Feb 2023

———

Rakesh Kumar

Independent Non-Executive Director

12 Aug 2024 (additional)

——65

Sandeep Chauhan

Additional Non-Executive Independent Director

2025———

Company Secretary

——

Reetika Mahendra signed the FY2023-24 AR filing (31 Aug 2024); current CS not confirmed

——

“—” = not publicly disclosed.

Board of Directors — Varsha Sethi

NameRolePeriod

Varsha Sethi

Chairman

c. 2013

Ajit Kumar Kasturchand (A.K.) Sethi

Director

2000s–2010s

Rajivkumar Sethi

Non-Executive Director

2018–2022

Dayanand Jagdish (D.N.) Jha

Director

1999–2022

K. Ramkrishnan

Director

c. 2013

Kalpita Laxman Sawant

Additional Director

2011–2010s

Rajendra (Rajender Lilaram) Gurnani

Director

c. 2013

Karthyayani Narayanan Kutty

Director

2017–2022

Governance Overview

AttributeStatus

Board size

~6 (1 executive, 1 non-executive promoter, 4 independent including additional director)

Independence

Majority independent on latest composition

Chair/CEO separation

Yes since May 2025 (Agarwal non-executive; Shah CEO)

Committees

Audit, Nomination & Remuneration, Stakeholders' Relationship (statutory); Agarwal listed as member of a committee in FY2024-25 AR; full composition not publicly disclosed in sources reviewed

Women directors

Shalu Saraf (1)

Compliance history

BSE "SOP fine" communication received July 2024 (Regulation 30 disclosure); historic suspension for listing non-compliance

Shareholding Trend

Holder categoryMar-2024 (%)Dec-2024 (%)Mar-2025 (%)Sep-2026 (%)

Promoters

58.6055.235.935.93

FIIs

0.000.220.020.00

Public (incl. foreign companies)

41.4044.5494.0494.07

No. of shareholders

8,9689,0569,0709,422

Major Shareholders

HolderShares%

Foreign companies (FCCB conversion allottees)

87,874,64189.88

Anubhav Agarwal (promoter)

5,800,0005.93

Resident individuals

3,437,4993.52

Body corporates

438,2620.45

Non-resident individuals

166,2740.17

Other shareholders

32,4390.03

Foreign portfolio investors

23,6260.02

Domestic institutions

2000.00

Total

97,772,941

100.00

Competitive Landscape

Key Competitors

CompetitorSegment overlapScale / data pointPositioning vs BN Agrochem

AWL Agri Business (formerly Adani Wilmar)

Edible oil refining, brands (Fortune), import trading

—

Vastly larger, integrated, branded

Patanjali Foods (formerly Ruchi Soya)

Edible oil processing, solvent extraction, brands

—

Integrated soybean/palm processor; similar solvent-extraction heritage

Gujarat Ambuja Exports (GAEL)

Agro-processing, solvent extraction, maize/soy

Market cap ₹7,825 Cr, P/E 18.8, annual PAT ₹304 Cr (Fyers peer table)

Profitable integrated processor; 9× BN Agrochem PAT

Gokul Agro Resources

Edible oil import, refining, trading

—

Closest listed model to an import-led trader-refiner

Cargill India

Edible oil refining & trading

Unlisted; not disclosed

Global trading major

Wilmar International / Olam (global)

Palm oil origination & trading (Singapore hubs)

—

Direct competitors to the Singapore subsidiary

Emami Agrotech

Edible oil refining

Unlisted/subsidiary; not disclosed

Regional brand competitor

Vijay Solvex

Solvent extraction & refining (Rajasthan)

—

Small-cap processor peer

Kriti Nutrients

Soybean solvent extraction

—

Small-cap processor peer

Bidco Africa / Murzah Wilmar

African edible oil and soaps

—

Incumbents in BN Group's targeted African markets

RBS (SME listing)

Trading (Fyers peer set)

Price ₹88.5, m-cap ₹212 Cr, P/E 18.6, PAT ₹11 Cr

Small trading peer

Shanti (Fyers peer set)

Trading

M-cap ₹7 Cr, loss-making

Micro peer

“—” = not publicly disclosed.

Peer Comparison FY2026

MetricBN AgrochemGujarat Ambuja ExportsRBS (SME)

Market cap

1,5357,825212

Annual PAT

3430411

P/E (x)

89.918.818.6

EV/EBITDA (x, Fyers)

1.83 (vendor figure; see note)

12.036.98

Company Snapshot

$100.8M

Revenue

1991

Founded

Mumbai, India

Headquarters

SWOT Analysis

Strengths

  • Rapid revenue scale-up: consolidated revenue rose from ₹7.09 Cr (FY2024) to ₹873.28 Cr (FY2026) — a ~123× increase in two years (Screener; company results).
  • Positive operating cash flow achieved: CFO turned from -₹38 Cr (FY2025) to +₹24 Cr (FY2026), CFO/EBITDA 123% (Screener).
  • Receivables discipline improved: debtor days fell from 352 to 59 between FY2025 and FY2026 (Screener).
  • Low leverage: borrowings of ₹51 Cr vs net worth ₹467 Cr at FY2026 (D/E ~0.11) (Screener).
  • Demonstrated offshore capital access: USD 40 M FCCB listed on AFRINEX, converted into equity, lifting net worth from ₹71 Cr to ₹392 Cr in FY2025 (Offering Memorandum; Screener).
  • Regulatory progress on consolidation: BSE NOC (4 Mar 2026), CCI approval (28 Apr 2026) and NCLT directions (19 Jun 2026) already secured for the amalgamation.

Weaknesses

  • Thin and volatile margins: quarterly OPM ranged from +11.71% (Q1FY26) to -8.41% (Q3FY26); FY2026 OPM 2.6% (Screener).
  • Earnings quality: FY2026 net profit (₹34.4 Cr) exceeded PBT (₹20 Cr) due to a -74% effective tax rate; Q2FY26 profit of ₹17.9 Cr came on PBT of ₹0.57 Cr (Screener).
  • Reliance on other income in FY2025: Q4FY25 operating loss of ₹40.55 Cr offset by ₹61.44 Cr other income (Screener).
  • Rising working capital: working-capital days increased from 79 to 172 (FY2025→FY2026) (Screener).
  • No owned production assets: fixed assets ~₹1 Cr against ₹873 Cr revenue (Screener).
  • Low returns: ROE ~8% in FY2026 (Screener) on a premium-inflated equity base; no dividends ever paid in the listed history reviewed.

Opportunities

  • Amalgamation brings operating assets: B.N. Agritech alone has ₹92.68 Cr of issued capital and listed NCDs, suggesting a substantive operating business (Scanx; MITCON NOC).
  • Africa expansion: BN Group plans USD 1 bn over 5 years, including USD 400 M for manufacturing (Deccan Herald, Dec 2024).
  • Domestic growth momentum: standalone revenue grew 808% in FY2026 and ~4× YoY in Q1FY27 (5paisa; ScanX).
  • Singapore hub: registered wholesale-palm-oil activity positions the group near origination markets (ACRA records).
  • Diversification optionality: objects expanded to renewable energy and IT services (Kotak Neo company background).
  • Index/NSE visibility: dual listing on NSE (BNAGROCHEM) broadens investor access (Screener).

Threats

  • Governance perception: 89.88% held by unnamed foreign companies post-FCCB, promoter at 5.93% (Fairness Opinion; Screener).
  • Related-party exposure: corporate guarantees of ₹15 Cr (Aug 2026) and ₹10 Cr (proposed Oct 2026) for promoter-group B.N. Agritech (ScanX; Groww).
  • Dilution risk: analyst estimate of ~18.4 Cr new shares under the scheme vs 9.78 Cr existing.
  • Share price volatility and regulatory scrutiny: -60% in 1 year; BSE clarification sought 13 Oct 2026 (Screener).
  • Commodity and FX risk: USD-denominated trading and USD-linked FCCB structure amid a weak rupee (~₹95.7/USD in Aug 2026 per a separate exchange disclosure).
  • Scheme timeline slippage: NCLT extension of 90 days granted 13 Aug 2026 (Screener announcements).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
21 May 2025Chintan Shah appointed WTD & CEO; Anubhav Agarwal to Non-Executive Director; Ashutosh Sharma resignsProfessionalisation; founder steps back to pursue overseas business
14 Jun 2025FY2025 audited results: revenue ₹299.4 Cr, net profit ₹19.8 Cr (consolidated)First full year of trading
28 Jun 2025Scheme of Amalgamation intimatedStart of group consolidation
23 Jul 2025Board's report for FY2024-25 signed; name change to proposed new name approved subject to ROCRebranding
7 Aug 2025Q1FY26 results: revenue ₹203.3 Cr, net profit ₹20.1 Cr (+1,146% YoY), OPM 11.7%Peak margin quarter
18 Aug 2025EGM approves CEO, independent director appointment and Agarwal's redesignation; RPT approvalsGovernance
Aug 2025Name changed to BN Agrochem LimitedIdentity aligned to agri business
15 Sep 2025Share price ~₹368, near 52-week high ₹375Valuation peak region
23 Sep 2025 (approx.)34th AGMAnnual compliance
4 Nov 2025FY2024-25 annual report filed with BSEDisclosure
13 Nov 2025Q2FY26 results: revenue ₹216.5 Cr, net profit ₹17.9 Cr largely from tax credit (PBT ₹0.57 Cr)Earnings quality concern
24 Nov 2025Market cap ~₹3,578 Cr (Kuvera)Approximate peak valuation
17 Dec 2025Revised scheme intimation; fairness and valuation reports published (incl. NCD exchange ratio)Scheme terms set
Dec 2025Combination notified to CCI (C-2025/12/1362)Regulatory step
13 Feb 2026Q3FY26 results: revenue ₹192.1 Cr (+125% YoY), net loss ₹6.8 Cr, OPM -8.4%First loss quarter post-ramp
4 Mar 2026BSE "no objection" observation letter on schemeExchange clearance
28 Apr 2026CCI approval of amalgamationCompetition clearance
29–31 May 2026FY2026 audited results: revenue ₹873.3 Cr (+192%), net profit ₹34.4 Cr (+74%); Q4 net profit ₹2.95 Cr (-83% YoY)Scale-up with thin margins
19 Jun 2026NCLT Mumbai orders shareholder and secured creditor meetings; swap ratios disclosedScheme progresses
22 Jun 2026Press coverage of NCLT orderMarket awareness
11 Aug 2026Q1FY27 results: revenue ₹257.6 Cr (+27% YoY), net profit ₹2.98 Cr (-85% YoY); ₹15 Cr guarantee for B.N. Agritech approved; one-year term appointment effective same dateMargin compression; rising group exposure
12 Aug 2026Results published in Financial Express and NavshaktiCompliance
13 Aug 2026NCLT grants 90-day extension to convene scheme meetingsTimeline slip
23 Sep 202635th AGM via video conferenceAnnual compliance
30 Sep 2026Newspaper publication (Reg. 30)Likely notice of scheme/EGM meetings
2 Oct 2026Regulation 30 update on NCLT extensionDisclosure
12 Oct 2026Reg. 74(5) certificate for Sep 2026 quarterRoutine
13 Oct 2026BSE seeks clarification on significant price movementVolatility; regulatory scrutiny
14 Oct 2026Company clarifies movement is market-driven, no undisclosed eventDisclosure
19 Oct 2026Stock closes ₹159 (-4.3% day), near 52-week low ₹158; -60% over 1 yearSentiment trough
22 Oct 2026 (scheduled)EGM incl. ₹10 Cr corporate guarantee for B.N. AgritechPending

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment: Edible oils & agri trading revenue rose from INR 70.9 Mn in FY2024 to INR 8,732.8 Mn in FY2026.
BN Agrochem Limited — Revenue by Segment
Series (INR Mn)FY2024FY2025FY2026
Edible oils & agri trading revenue70.92,994.18,732.8
Segment operating profit / EBITDA-30.970220

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. 1Screener.in — BN Agrochem Ltd (consolidated & standalone), accessed 19 Oct 2026: — Financials, ratios, shareholding, price, announcements (screener.in)
  2. 2BN Holdings Annual Report 2022-23: — Business description, acquisition, incorporation date (bn-holdings.com)
  3. 3BN Holdings Annual Report 2023-24 (BSE filing, 31 Aug 2024): — Strategy, directors (bseindia.com)
  4. 4BN Agrochem Annual Report 2024-25: and BSE filing of 4 Nov 2025 — Board changes, RPTs, subsidiaries (bn-holdings.com)
  5. 5Arihant Tournesol Annual Reports FY2013, FY2014, FY2018, FY2021 (BSE archives) — Historic board, auditor, addresses
  6. 6FCCB Offering Memorandum, BN Holdings Limited (AFRINEX): — FCCB terms (afrinexexchange.com)
  7. 7Fairness Opinion — Scheme of Amalgamation: — Shareholding, promoter stakes (bn-holdings.com)
  8. 8Valuation / NCD fairness reports and MITCON NOC (bnagritech.com, Dec 2025) — Scheme structure, NCDs
  9. 9ScanX news on BSE NOC, NCLT order, Q1FY27 results, EGM, AGM (2025–2026) — Newsflow
  10. 10Whalesbook — NCLT order and swap ratios (Jun 2026) — Swap ratios, share capital
  11. 115paisa, Kotak Neo, IndMoney, Business Standard, Fyers results pages — Annual/quarterly results, peers, price points
  12. 12Deccan Herald via farmlandgrab.org (17 Dec 2024) — BN Group Africa plan
  13. 13MarketScreener, Investing.com, Sharekhan, Blinkx, Investyadnya, Kuvera — Management, history, ISIN, market cap
  14. 14ACRA/LEI records for BN Holdings Singapore Pte. Ltd — Subsidiary details
  15. 15bn-holdings.com disclosures page — Reg. 30 filings register
  16. 16Groww announcements page — EGM Oct 2026, guarantee

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.